Global Helicobacter Pylori Non-Invasive Testing Market Growth (Status and Outlook) 2023-2029

Global Helicobacter Pylori Non-Invasive Testing Market Growth (Status and Outlook) 2023-2029

Helicobacter pylori is a type of bacteria that is known to be a major cause of peptic ulcers, which are sores on the lining of the esophagus, stomach or small intestine. H. pylori testing detects an infection of the digestive tract caused by the bacteria to help diagnose the cause of symptoms and/or ulcers.



H. pylori infections of the digestive tract are very common, with as many as half of the world’s population infected. However, most people with H. pylori never have any symptoms. Still, H. pylori infection increases the risk of developing ulcers (peptic ulcer disease), persistent stomach inflammation (gastritis), and gastric (stomach) cancer. The bacteria decrease the stomach’s ability to produce mucus, making the stomach prone to damage from digestive acid and peptic ulcers.

LPI (LP Information)' newest research report, the “Helicobacter Pylori Non-Invasive Testing Industry Forecast” looks at past sales and reviews total world Helicobacter Pylori Non-Invasive Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Helicobacter Pylori Non-Invasive Testing sales for 2023 through 2029. With Helicobacter Pylori Non-Invasive Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helicobacter Pylori Non-Invasive Testing industry.

This Insight Report provides a comprehensive analysis of the global Helicobacter Pylori Non-Invasive Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Helicobacter Pylori Non-Invasive Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Helicobacter Pylori Non-Invasive Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helicobacter Pylori Non-Invasive Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helicobacter Pylori Non-Invasive Testing.

The global Helicobacter Pylori Non-Invasive Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Helicobacter Pylori Non-Invasive Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Helicobacter Pylori Non-Invasive Testing players cover Abbott, Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories and EKF Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Helicobacter Pylori Non-Invasive Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Serologic Test
Urea Breath Test (UBT)
Stool Antigen Test (SAT)

Segmentation by application
Hospitals
Clinics
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health, Inc
Cardinal Health
Beckman Coulter Inc
Agilent Technologies
Coris BioConcept

Please note: The report will take approximately 2 business days to prepare and deliver.